Letter in response to David N. Louis et al, International Society of Neuropathology-Haarlem Consensus Guidelines for Nervous System Tumor Classification and Grading, Brain Pathology, doi: 10.1111/bpa.12171.
作者信息
Hainfellner Johannes, Louis David N, Perry Arie, Wesseling Pieter
机构信息
Institute of Neurology, Medical University of Vienna, Vienna, Austria.
出版信息
Brain Pathol. 2014 Nov;24(6):671-2. doi: 10.1111/bpa.12187.
Abstract
摘要
相似文献
1
Letter in response to David N. Louis et al, International Society of Neuropathology-Haarlem Consensus Guidelines for Nervous System Tumor Classification and Grading, Brain Pathology, doi: 10.1111/bpa.12171.
Brain Pathol. 2014 Nov;24(6):671-2. doi: 10.1111/bpa.12187.
2
International Society Of Neuropathology--Haarlem consensus guidelines for nervous system tumor classification and grading.
Brain Pathol. 2014 Sep;24(5):429-35. doi: 10.1111/bpa.12171. Epub 2014 Sep 10.
3
Coding for neuro-oncology.
Continuum (Minneap Minn). 2015 Apr;21(2 Neuro-oncology):487-98. doi: 10.1212/01.CON.0000464184.12452.15.
4
The WHO classification of tumors of the nervous system.
J Neuropathol Exp Neurol. 2002 Mar;61(3):215-25; discussion 226-9. doi: 10.1093/jnen/61.3.215.
5
[The classification of nervous system tumors].
Zh Vopr Neirokhir Im N N Burdenko. 1998 Jan-Mar(1):13-5.
6
[The new WHO classification of tumors of the nervous system 2000. Pathology and genetics].
Pathologe. 2002 Jul;23(4):260-83. doi: 10.1007/s00292-002-0530-8.
7
An appraisal of the World Health Organization classification of tumors of the central nervous system.
Cancer. 1985 Oct 1;56(7 Suppl):1858-64. doi: 10.1002/1097-0142(19851001)56:7+<1858::aid-cncr2820561328>3.0.co;2-i.
8
[Clinical aspects of nervous system tumors in dogs and cats].
Schweiz Arch Tierheilkd. 1981 Nov;123(11):553-71.
9
New approaches to the molecular biology, classification, and therapy of nervous system tumors: a workshop of the National Institutes of Health Pathology B study section.
Am J Pathol. 2001 Nov;159(5):1971-4. doi: 10.1016/s0002-9440(10)63044-1.
10
Update on diagnostic practice: tumors of the nervous system.
Arch Pathol Lab Med. 2009 Jul;133(7):1062-77. doi: 10.5858/133.7.1062.
引用本文的文献
1
Diagnostic performance of gliomas grading and IDH status decoding A comparison between 3D amide proton transfer APT and four diffusion-weighted MRI models.
J Magn Reson Imaging. 2022 Dec;56(6):1834-1844. doi: 10.1002/jmri.28211. Epub 2022 Apr 30.
2
Transcriptional Networks Identify BRPF1 as a Potential Drug Target Based on Inflammatory Signature in Primary Lower-Grade Gliomas.
Front Oncol. 2021 Dec 2;11:766656. doi: 10.3389/fonc.2021.766656. eCollection 2021.
3
The Systematic Landscape of Nectin Family and Nectin-Like Molecules: Functions and Prognostic Value in Low Grade Glioma.
Front Genet. 2021 Dec 1;12:718717. doi: 10.3389/fgene.2021.718717. eCollection 2021.
4
Integrative Analyses and Verification of the Expression and Prognostic Significance for RCN1 in Glioblastoma Multiforme.
Front Mol Biosci. 2021 Oct 13;8:736947. doi: 10.3389/fmolb.2021.736947. eCollection 2021.
5
A Novel Six Autophagy-Related Genes Signature Associated With Outcomes and Immune Microenvironment in Lower-Grade Glioma.
Front Genet. 2021 Oct 13;12:698284. doi: 10.3389/fgene.2021.698284. eCollection 2021.
6
The Multifaceted Glioblastoma: From Genomic Alterations to Metabolic Adaptations.
Adv Exp Med Biol. 2021;1311:59-76. doi: 10.1007/978-3-030-65768-0_4.
7
Novel Immune-Related Gene Signature for Risk Stratification and Prognosis of Survival in Lower-Grade Glioma.
Front Genet. 2020 Apr 15;11:363. doi: 10.3389/fgene.2020.00363. eCollection 2020.
8
Reclassification of Mongolian Diffuse Gliomas According to the Revised 2016 World Health Organization Central Nervous System Tumor Classification.
J Pathol Transl Med. 2019 Sep;53(5):298-307. doi: 10.4132/jptm.2019.07.15. Epub 2019 Aug 2.
9
Epigenetic silencing of XAF1 in high-grade gliomas is associated with IDH1 status and improved clinical outcome.
Oncotarget. 2017 Feb 28;8(9):15071-15084. doi: 10.18632/oncotarget.14748.
10
Ki-67 proliferation index but not mitotic thresholds integrates the molecular prognostic stratification of lower grade gliomas.
Oncotarget. 2016 Apr 19;7(16):21190-8. doi: 10.18632/oncotarget.8498.
本文引用的文献
1
Clinical neuropathology practice guide 3-2013: levels of evidence and clinical utility of prognostic and predictive candidate brain tumor biomarkers.
Clin Neuropathol. 2013 May-Jun;32(3):148-58. doi: 10.5414/np300646.
2
NCCN Task Force report: Evaluating the clinical utility of tumor markers in oncology.
J Natl Compr Canc Netw. 2011 Nov;9 Suppl 5:S1-32; quiz S33. doi: 10.6004/jnccn.2011.0137.
Zotero 插件